Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$5.13 - $9.2 $150,642 - $270,158
-29,365 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$8.64 - $11.71 $339,396 - $459,992
-39,282 Reduced 57.22%
29,365 $254,000
Q4 2021

Feb 14, 2022

BUY
$10.95 - $16.07 $122,661 - $180,016
11,202 Added 19.5%
68,647 $764,000
Q3 2021

Nov 15, 2021

BUY
$12.95 - $18.24 $346,295 - $487,755
26,741 Added 87.09%
57,445 $744,000
Q2 2021

Aug 16, 2021

SELL
$15.83 - $17.84 $429,040 - $483,517
-27,103 Reduced 46.89%
30,704 $508,000
Q1 2021

May 17, 2021

SELL
$15.92 - $20.3 $52,201 - $66,563
-3,279 Reduced 5.37%
57,807 $993,000
Q4 2020

Feb 16, 2021

SELL
$15.65 - $19.92 $40,830 - $51,971
-2,609 Reduced 4.1%
61,086 $956,000
Q3 2020

Nov 16, 2020

SELL
$13.97 - $21.16 $206,853 - $313,316
-14,807 Reduced 18.86%
63,695 $1.22 Million
Q2 2020

Aug 17, 2020

BUY
$10.39 - $16.07 $353,176 - $546,251
33,992 Added 76.37%
78,502 $1.08 Million
Q1 2020

May 15, 2020

BUY
$8.89 - $24.94 $148,062 - $415,375
16,655 Added 59.79%
44,510 $473,000
Q4 2019

Feb 14, 2020

BUY
$8.33 - $19.95 $44,248 - $105,974
5,312 Added 23.56%
27,855 $520,000
Q3 2019

Nov 14, 2019

BUY
$6.86 - $10.46 $154,644 - $235,799
22,543 New
22,543 $236,000

Others Institutions Holding XBIT

About XBiotech Inc.


  • Ticker XBIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,439,300
  • Market Cap $137M
  • Description
  • XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...
More about XBIT
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.